From: Development and clinical evaluation of a rapid antibody lateral flow assay for the diagnosis of SARS-CoV-2 infection
Samples
Total samples (n)
Positive rate
(%)
p
COVID-19 patients
97
88.65 (86/97)
0.000
Suspected COVID-19 patients
43
53.48 (23/43)
General fever or pulmonary infection patients
88
4.55 (4/88)